专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

61. 发明授权

US08897156B2 Method and apparatus for uplink synchronization control 有权
标题翻译：用于上行链路同步控制的方法和装置
公开(公告)号：US08897156B2
公开(公告)日：2014-11-25
申请号：US13320537
申请日：2010-05-11
申请人： Zhixue Wang , Guoqing Li , Yi Zhao , Jiamin Liu , Yali Zhao , Fangli Xu
发明人： Zhixue Wang , Guoqing Li , Yi Zhao , Jiamin Liu , Yali Zhao , Fangli Xu
IPC分类号： H04J3/14 , H04J3/06
CPC分类号： H04W56/0045 , H04W92/10
摘要： The present invention discloses a method for uplink synchronization control, wherein network side and a user equipment (UE) maintain a timing alignment timer (TAT) for the UE, and maintain an uplink transmission timing adjustment amount for uplink component carriers, and the method includes following steps: the network side measuring uplink component carriers of the UE, and obtaining an uplink transmission TA amount of the uplink component carriers; and before the TAT expires, the network side transmitting to the UE an adjustment command comprising information of the uplink transmission TA amount for at least one of the uplink component carriers of the UE. Also disclosed in the embodiments of the present invention are a method for uplink synchronization control at the UE side, and a base station and a UE for implementing the above methods. The solution of the present invention enables accurate adjustment of the uplink synchronization for each component carrier in a carrier aggregation mechanism.
摘要翻译：本发明公开了一种上行链路同步控制方法，其中网络侧和用户设备（UE）维护用于UE的定时对准定时器（TAT），并维持上行链路分量载波的上行链路传输定时调整量，该方法包括以下步骤：网络侧测量UE的上行链路分量载波，并获得上行链路分量载波的上行链路传输TA量; 并且在TAT到期之前，网络侧向UE发送包括UE的上行链路分量载波中的至少一个的上行链路传输TA的信息的调整命令。在本发明的实施例中也公开了一种用于UE侧的上行链路同步控制的方法，以及用于实现上述方法的基站和UE。本发明的解决方案能够准确地调整载波聚合机制中的每个分量载波的上行链路同步。

62. 发明申请

US20140206715A1 PREPARATION AND USE OF COMPOUNDS AS PROTEASE INHIBITORS 审中-公开
标题翻译：化合物作为蛋白酶抑制剂的制备和使用
公开(公告)号：US20140206715A1
公开(公告)日：2014-07-24
申请号：US14226338
申请日：2014-03-26
申请人： Andrew W. Stamford , Guoqing Li , William Greenlee , Zhaoning Zhu , Brian McKittrick , Robert Mazzola , Ying Huang , Tao Guo , Thuy X.E. Le , Gang Qian , Yuefei Shao
发明人： Andrew W. Stamford , Guoqing Li , William Greenlee , Zhaoning Zhu , Brian McKittrick , Robert Mazzola , Ying Huang , Tao Guo , Thuy X.E. Le , Gang Qian , Yuefei Shao
IPC分类号： C07D471/04
CPC分类号： C07D471/04 , C07D209/44 , C07D487/04
摘要： Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein Q is a bond or —N(R5)—; T is a bond, —O—, —C(O)—; S, —N(R5)—, or —C(R6′R7′); U is a bond or —C(R6)(R7)— Y is C or N; Z is C or N; ring A, including variables Y and Z, is a three to nine membered cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, aryl, and heteroaryl ring having 0 to 4, preferably 0 to 2, heteroatoms independently selected from the group consisting of O, S, N and —N(R)—, wherein ring A is unsubstituted or substituted with 1 to 5 independently selected R1 moieties and/or oxo when ring A is cycloalkyl, cycloalkenyl, heterocyclyl or heterocyclenyl; and R, R1, R2, R3, R4, R5, R6, R6, R7 and R7′ are as defined in the specification; pharmaceutical compositions comprising the compounds of formula I and the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases.
摘要翻译：公开了式I化合物或其立体异构体，互变异构体或其药学上可接受的盐或溶剂合物，其中Q是键或-N（R 5） - ; T是键，-O - ， - C（O） - ; S，-N（R 5） - 或-C（R 6'R 7'）; U是键或-C（R6）（R7）-Y是C或N; Z是C或N; 环A包括变量Y和Z是具有0至4个，优选0至2个杂原子的3至9元环烷基，环烯基，杂环基，杂环烯基，芳基和杂芳基环，其独立地选自O，S， N和-N（R） - ，其中当环A是环烷基，环烯基，杂环基或杂环烯基时，环A是未取代的或被1至5个独立选择的R 1部分和/或氧代取代。并且R，R 1，R 2，R 3，R 4，R 5，R 6，R 6，R 7和R 7'如本说明书中所定义; 包含式I化合物的药物组合物和抑制天冬氨酰蛋白酶的方法，特别是治疗心血管疾病，认知和神经变性疾病的方法。

63. 发明授权

US08722708B2 Substituted isoindolines as aspartyl protease inhibitors 有权
标题翻译：取代的异吲哚啉作为天冬氨酰蛋白酶抑制剂
公开(公告)号：US08722708B2
公开(公告)日：2014-05-13
申请号：US11451065
申请日：2006-06-12
申请人： Andrew Stamford , Guoqing Li , William Greenlee , Zhaoning Zhu , Brian McKittrick , Robert Mazzola , Ying Huang , Tao Guo , Thuy X. H. Le , Gang Qian , Yuefei Shao
发明人： Andrew Stamford , Guoqing Li , William Greenlee , Zhaoning Zhu , Brian McKittrick , Robert Mazzola , Ying Huang , Tao Guo , Thuy X. H. Le , Gang Qian , Yuefei Shao
IPC分类号： C07D487/04 , A61K31/519 , A61K31/4035 , A61K31/4406 , C07D487/14 , A61K31/437 , A61P25/28 , A61P9/00 , A61P31/14
CPC分类号： C07D471/04 , C07D209/44 , C07D487/04
摘要： Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein Q is a bond or —N(R5)—; T is a bond, —O—, —C(O)—; S, —N(R5)—, or —C(R6′R7′); U is a bond or —C(R6)(R7)— Y is C or N; Z is C or N; ring A, including variables Y and Z, is a three to nine membered cycloalkyl, cycloalkenyl, heterocyclyl, heterocyclenyl, aryl, and heteroaryl ring having 0 to 4, preferably 0 to 2, heteroatoms independently selected from the group consisting of O, S, N and —N(R)—, wherein ring A is unsubstituted or substituted with 1 to 5 independently selected R1 moieties and/or oxo when ring A is cycloalkyl, cycloalkenyl, heterocyclyl or heterocyclenyl; and R, R1, R2, R3, R4, R5, R6, R6, R7 and R7′ are as defined in the specification; pharmaceutical compositions comprising the compounds of formula I and the method of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases.
摘要翻译：公开了式I化合物或其立体异构体，互变异构体或其药学上可接受的盐或溶剂合物，其中Q是键或-N（R 5） - ; T是键，-O - ， - C（O） - ; S，-N（R 5） - 或-C（R 6'R 7'）; U是键或-C（R6）（R7）-Y是C或N; Z是C或N; 环A包括变量Y和Z是具有0至4个，优选0至2个杂原子的3至9元环烷基，环烯基，杂环基，杂环烯基，芳基和杂芳基环，其独立地选自O，S， N和-N（R） - ，其中当环A是环烷基，环烯基，杂环基或杂环烯基时，环A是未取代的或被1至5个独立选择的R 1部分和/或氧代取代。并且R，R 1，R 2，R 3，R 4，R 5，R 6，R 6，R 7和R 7'如本说明书中所定义; 包含式I化合物的药物组合物和抑制天冬氨酰蛋白酶的方法，特别是治疗心血管疾病，认知和神经变性疾病的方法。

64. 发明授权

US08691833B2 Heterocyclic aspartyl protease inhibitors 有权
标题翻译：杂环天门冬氨酰蛋白酶抑制剂
公开(公告)号：US08691833B2
公开(公告)日：2014-04-08
申请号：US13415404
申请日：2012-03-08
申请人： Zhaoning Zhu , Brian McKittrick , Zhong-Yue Sun , Yuanzan C. Ye , Johannes H. Voight , Corey O. Strickland , Elizabeth M. Smith , Andrew W. Stamford , William J. Greenlee , Robert D. Mazzola, Jr. , John P. Caldwell , Jared N. Cumming , Lingyan Wang , Yusheng Wu , Ulrich Iserloh , Xiaoiang Liu , Tao Guo , Thuy X.E. Le , Kurt W. Saionz , Suresh D. Babu , Rachael C. Hunter , Michelle L. Morris , Huizhong Gu , Gang Qian , Dawit Tadesse , Ying Huang , Guoqing Li , Jianping Pan , Jeffrey A. Misiaszek , Gaifa Lai , Jingqi Duo , Chuanxing Qu , Yuefei Shao
发明人： Zhaoning Zhu , Brian McKittrick , Zhong-Yue Sun , Yuanzan C. Ye , Johannes H. Voight , Corey O. Strickland , Elizabeth M. Smith , Andrew W. Stamford , William J. Greenlee , Robert D. Mazzola, Jr. , John P. Caldwell , Jared N. Cumming , Lingyan Wang , Yusheng Wu , Ulrich Iserloh , Xiaoiang Liu , Tao Guo , Thuy X.E. Le , Kurt W. Saionz , Suresh D. Babu , Rachael C. Hunter , Michelle L. Morris , Huizhong Gu , Gang Qian , Dawit Tadesse , Ying Huang , Guoqing Li , Jianping Pan , Jeffrey A. Misiaszek , Gaifa Lai , Jingqi Duo , Chuanxing Qu , Yuefei Shao
IPC分类号： A01N43/54 , A61K31/505 , C07D239/02
CPC分类号： C07D233/88 , A61K31/4168 , A61K31/4178 , C07D239/22 , C07D401/06 , C07D401/10 , C07D403/06 , C07D409/04 , C07D409/14 , C07D413/04 , C07D417/10 , C07D417/14 , C07D495/10
摘要： Disclosed are compounds of the formula I or a stereoisomer, tautomer, or pharmaceutically acceptable salt or solvate thereof, wherein each variable in Formula 1 are as defined in the specification; and pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of inhibiting aspartyl protease, and in particular, the methods of treating cardiovascular diseases, cognitive and neurodegenerative diseases, and the methods of inhibiting of Human Immunodeficiency Virus, plasmepins, cathepsin D and protozoal enzymes. Also disclosed are methods of treating cognitive or neurodegenerative diseases using the compounds of formula I in combination with a cholinesterase inhibitor or a muscarinic m1 agonist or m2 antagonist.
摘要翻译：公开了式I化合物或其立体异构体，互变异构体或其药学上可接受的盐或溶剂化物，其中式1中的每个变量如说明书中所定义; 以及包含式I化合物的药物组合物。还公开了抑制天冬氨酰蛋白酶的方法，特别是治疗心血管疾病，认知和神经退行性疾病的方法，以及抑制人类免疫缺陷病毒，plasmepins，组织蛋白酶D和原生动物酶。还公开了使用式I化合物与胆碱酯酶抑制剂或毒蕈碱m1激动剂或m2拮抗剂组合治疗认知或神经变性疾病的方法。

65. 发明申请

US20140031038A1 METHOD AND APPARATUS FOR DEVICE HANDOVER 有权
标题翻译：用于设备切换的方法和装置
公开(公告)号：US20140031038A1
公开(公告)日：2014-01-30
申请号：US14002114
申请日：2012-01-13
申请人： Ying Wang , Guoqing Li , Chen Li
发明人： Ying Wang , Guoqing Li , Chen Li
IPC分类号： H04W36/26
CPC分类号： H04W36/26 , H04W4/06 , H04W36/0083
摘要： Disclosed in the present invention are a method and an apparatus for device handover, which belongs to the mobile communication field. The method comprises the following steps: obtaining a Multimedia. Broadcast Multicast Service (MBMS) service configuration information of neighbor cells; selecting a target cell for a user equipment according to the MBMS service configuration information of the neighbor cells and the MBMS service reception information of the user equipment; handing over the user equipment to the target cell. The apparatus comprises: an acquiring module, for obtaining the Multimedia Broadcast Multicast Service (MBMS) service configuration information of the neighbor cells; a selecting module, for selecting a target cell for a user equipment according to the MBMS service configuration information of the neighbor cells and the MBMS service reception information of the user equipment; a handover module, for handing over the user equipment to the target cell. With the implementation of the technical solution that the MBMS service configuration information of the neighbor cells is obtained, the target cell for the user equipment is selected according to the MBMS service configuration information and the MBMS service reception information of the user equipment, and the user equipment is handed over to the target cell, the present invention enables the user equipment to switch to an appropriate target cell.
摘要翻译：在本发明中公开了一种属于移动通信领域的设备切换的方法和装置。该方法包括以下步骤：获得多媒体。相邻小区的广播组播业务（MBMS）业务配置信息; 根据相邻小区的MBMS服务配置信息和用户设备的MBMS服务接收信息，选择用户设备的目标小区; 将用户设备交给目标小区。该装置包括：获取模块，用于获取相邻小区的多媒体广播多播服务（MBMS）业务配置信息; 选择模块，用于根据相邻小区的MBMS服务配置信息和用户设备的MBMS服务接收信息来选择用户设备的目标小区; 切换模块，用于将用户设备移交给目标小区。通过实现获得相邻小区的MBMS服务配置信息的技术方案，根据用户设备的MBMS服务配置信息和MBMS服务接收信息来选择用户设备的目标小区，用户设备被切换到目标小区，本发明使得用户设备能够切换到适当的目标小区。

66. 发明申请

US20140029503A1 Wireless Clone Mode Display 有权
标题翻译：无线克隆模式显示
公开(公告)号：US20140029503A1
公开(公告)日：2014-01-30
申请号：US13947170
申请日：2013-07-22
申请人： Srikanth Kambhatla , Guoqing Li
发明人： Srikanth Kambhatla , Guoqing Li
IPC分类号： H04W28/02
CPC分类号： H04W28/02 , G06F3/1423 , G06F3/1454 , G09G2340/0407 , G09G2350/00 , G09G2370/025 , G09G2370/045 , G09G2370/10 , G09G2370/12 , G09G2370/16 , H04N21/4122 , H04N21/43615 , H04N21/43635 , H04N21/43637 , H04W80/00
摘要： Wireless sinks, such as displays, may receive wirelessly transmitted audio/video information in clone mode. In one embodiment, the same audio/video stream may be provided to a plurality of sinks daisy chained from a wireless receiver.
摘要翻译：诸如显示器的无线接收器可以以克隆模式接收无线传输的音频/视频信息。在一个实施例中，相同的音频/视频流可以被提供给从无线接收器菊花链链接的多个接收器。

67. 发明授权

US08619617B2 Data transmission method, system and device in multi-carrier system 有权
标题翻译：多载波系统中的数据传输方法，系统和设备
公开(公告)号：US08619617B2
公开(公告)日：2013-12-31
申请号：US13578234
申请日：2011-01-30
申请人： Yali Zhao , Guoqing Li , Fangli Xu
发明人： Yali Zhao , Guoqing Li , Fangli Xu
IPC分类号： H04L12/28
CPC分类号： H04W72/1252 , H04L5/001
摘要： A data transmission method, system and device in multi-carrier system, which relate to wireless communication field, are provided for solving the problem, that is, when the scheduling methods for same time unit in the network side of multi-carrier system include Semi-Persistent Scheduling (SPS) and dynamic scheduling at the same time, how the terminal transmits data in said time unit. Before transmitting the uplink data by using the time unit, the terminal determines that the network side schedules the terminal to implement SPS uplink transmission and dynamic scheduling uplink transmission in the time unit by using the uplink component carrier and the number of uplink component carriers which can be used to implement uplink transmission by the terminal is more than one; the terminal selects parts or all of multiple available uplink component carriers, and implements SPS uplink transmission and/or dynamic scheduling uplink transmission in the time unit by using the selected uplink component carriers.
摘要翻译：提供了与无线通信领域相关的多载波系统中的数据传输方法，系统和装置，用于解决问题，即当多载波系统的网络侧的同一时间单元的调度方法包括半 - 一致的调度（SPS）和动态调度的同时，终端如何在所述时间单元中传输数据。在通过使用时间单元发送上行链路数据之前，终端确定网络侧通过使用上行链路分量载波和上行链路分量载波的数量来确定网络侧在时间单位中执行SPS上行链路传输和动态调度上行链路传输，用于实现上行传输的终端是多个; 终端选择多个可用上行链路分量载波的部分或全部，并且通过使用所选择的上行链路分量载波，在时间单元中实现SPS上行链路传输和/或动态调度上行链路传输。

68. 发明申请

US20130315118A1 IMPLEMENTING AN INTER-PAL PASS-THROUGH 有权
标题翻译：实现间歇式通过
公开(公告)号：US20130315118A1
公开(公告)日：2013-11-28
申请号：US13995637
申请日：2011-12-22
申请人： Guoqing Li , Carlos Cordeiro , Bahareh Sadeghi
发明人： Guoqing Li , Carlos Cordeiro , Bahareh Sadeghi
IPC分类号： H04L29/06
CPC分类号： H04L69/08 , H04L69/32 , H04W80/00 , H04W84/12
摘要： A system and method are provided that implement an inter-protocol adaptation layer (inter-PAL) pass-through processing scheme in wireless communicating devices operating with separate PALs to combine use of the individually-beneficial features of one PAL by allowing a first order capability for cross-talk between the PALs. A first PAL data packet is passed through the communicating system using a second PAL syntax. In so doing, a capacity to employ beneficial features of the second PAL advantageously in enhancement of the information in a data packet generated according to the first PAL is provided.
摘要翻译：提供了一种系统和方法，其在与单独的PAL操作的无线通信设备中实现协议间适配层（inter-PAL）直通处理方案，以通过允许一级能力来组合使用一个PAL的单独有益特征用于PAL间的串扰。第一PAL数据分组通过第二PAL语法通过通信系统。这样做，提供了有利于增强根据第一PAL产生的数据包中的信息的第二PAL的有益特征的能力。

69. 发明申请

US20130286917A1 METHOD AND DEVICE FOR COMPENSATION AND RESTORING OF COVERAGE AREA 有权
标题翻译：用于补偿和恢复覆盖区域的方法和装置
公开(公告)号：US20130286917A1
公开(公告)日：2013-10-31
申请号：US13978389
申请日：2012-01-06
申请人： Beibei Jia , Li Chen , Dajun Zhang , Ying Wang , Guoqing Li
发明人： Beibei Jia , Li Chen , Dajun Zhang , Ying Wang , Guoqing Li
IPC分类号： H04W52/02
CPC分类号： H04W52/02 , H04W52/0206 , Y02D70/1262
摘要： Disclosed is a method for compensation and restoring of a coverage area, for realizing energy saving and compensation between nodes. The coverage compensation method includes: judging whether or not the trigger condition for starting an energy saving and compensation process is satisfied according to a preset energy saving and compensation strategy; when the trigger condition for starting the energy saving and compensation process is satisfied, one of a first node and a second node carries out an energy saving operation in the energy saving and compensation process while the other node carries out a compensation operation in the energy saving and compensation process; wherein the first node is a compensation node and the second node is an energy saving node, or the first node is an energy saving node and the second node is a compensation node. Further disclosed is a device for implementing the method.
摘要翻译：公开了一种覆盖区域的补偿和恢复方法，用于实现节点之间的节能和补偿。覆盖补偿方法包括：根据预设的节能和补偿策略判断是否满足启动节能和补偿处理的触发条件; 当满足用于启动节能和补偿处理的触发条件时，第一节点和第二节点中的一个在节能和补偿过程中执行节能操作，而另一个节点在节能中执行补偿操作和补偿程序; 其中所述第一节点是补偿节点，所述第二节点是节能节点，或者所述第一节点是节能节点，所述第二节点是补偿节点。进一步公开的是用于实现该方法的装置。

70. 发明授权

US08541427B2 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use 有权
标题翻译：苯基取代的2-亚氨基-3-甲基吡咯并嘧啶酮化合物作为BACE-1抑制剂，组合物及其用途
公开(公告)号：US08541427B2
公开(公告)日：2013-09-24
申请号：US12988461
申请日：2009-04-21
申请人： Andrew W. Stamford , Zhaoning Zhu , Mihirbaran Mandal , Yusheng Wu , Jared N. Cumming , Xiaoxiang Liu , Guoqing Li , Ulrich Iserloh
发明人： Andrew W. Stamford , Zhaoning Zhu , Mihirbaran Mandal , Yusheng Wu , Jared N. Cumming , Xiaoxiang Liu , Guoqing Li , Ulrich Iserloh
IPC分类号： C07D487/04 , A61K31/519 , A61P25/28 , A61P3/10
CPC分类号： C07D487/04
摘要： In its many embodiments, the present invention provides certain 2-imino-3-methyl pyrrolo pyrimidone compounds, including compounds Formula (II): and include tautomers, steroisomers, or pharmaceutically acceptable salts or solvates of said compounds, stereoisomers, or said tautomers, wherein R2, R3, R4, R5, R6, R7, R8, and R9 are each selected independently and as defined herein. Pharmaceutical compositions comprising one or more such compounds, and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's Disease, are also disclosed.
摘要翻译：在其许多实施方案中，本发明提供某些2-亚氨基-3-甲基吡咯烷酮化合物，包括式（II）化合物：并且包括所述化合物，立体异构体或所述互变异构体的互变异构体，立体异构体或药学上可接受的盐或溶剂化物，其中R2，R3，R4，R5，R6，R7，R8和R9各自独立地并如本文所定义。还公开了包含一种或多种这样的化合物的药物组合物，及其制备和用于治疗与包括阿尔茨海默病在内的淀粉样蛋白β（Abeta）蛋白相关的病理学的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式